logging in or signing up Responsive drug delivery sysems mohanamarimuthu Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: Embed: Flash iPad Copy Does not support media & animations WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 5232 Category: Science & Tech.. License: All Rights Reserved Like it (6) Dislike it (0) Added: May 13, 2008 This Presentation is Public Favorites: 0 Presentation Description Future of drug delivery Comments Posting comment... Premium member Presentation Transcript Responsive Drug Delivery SystemsApplying micromachining, biosensors, telemetry, andother techniques at the interface of analytical chemistryand bioengineering to revolutionize drug delivery. : Responsive Drug Delivery SystemsApplying micromachining, biosensors, telemetry, andother techniques at the interface of analytical chemistryand bioengineering to revolutionize drug delivery. Sapna K. Deo, Elissavet A. Moschou, Serban F. Peteu, Leonidas G. Bachas, Sylvia Daunert - University of Kentucky Patricia E. Eisenhardt, ChipRx, Marc J. Madou - University of California – Irvine Mohana Marimuthu 200840090 Overview : Overview Introduction Responsive drug delivery Sensing Delivery Microfabrication Telemetry Future perspectives and challenges Introduction : Introduction Drug absorption, distribution and metabolism vary among individuals Individualized therapy Controlled release low therapeutic index high patient compliance Cannot respond – individuals drug therapy Responsive drug delivery : Responsive drug delivery Located inside patient’s body- sense-deliver drug ICD (implantable cardio defibrillator) – monitors heart beat Sensing: highly sensitive, selective and robust sensors-monitor small volumes of body fluids Protein engineering, molecular biology-bioreagents-biosensors Human physiology, physiological fluids- affect biosensors : Glucowatch- reverse iontophoresis- interstitial fluid. Medtronic MiniMed sensor, MiniMed’s 2007 implantable insulin pump- 72 hrs Alpha Dx, the OPTI critical care analyser, the senDX 100, I-Stat point of care blood analysis Advantage of closed loop drug delivery: life sustaining benefit for cardiac serve as alarm – angina, stroke, cancer, etc Slide 6: Limitations: Biocompatability and foreign body response Solutions: use of biomimetic surfaces, polyethylene oxide coatings, NO – releasing material Delivery: 2 types of commercial delivery system 1. implantable infusion pump 2. noninvasive reverse iontophoretic devices Piezo actuated silicon micropump using MEMS – size 16X12X1.86mm, flow rate – 100 µl/h. Slide 7: Types of drug delivery systems. Commercially available Implantable fusion pumps Noninvasive reverse ion- tophoresis devices Controlled release Duros implant technology Responsive Closed loop Responsive polymers Micro and miniature systems Microfabricated “sacrificial” valves “Artificial muscle” miniature valves Main features Preprogrammed to deliver at any release rate through a catheter to a specific body location Electric current applied across skin to extract analyte from within/beneath the skin Continuous release for pain medication, individually tailored using an osmotic gradient Delivers as a function of sensor signal;includes sensing and release systems Release from a smart polymer in response to a stimulus Contains nano- to low-microliter volumes of therapeutic agents in individually sealed reservoirs; drug is released by electrochemically removing each microvial’s lid Based on a soft hydrogel and polymer blend that mimics natural muscle functions Slide 8: Duros – controlled release device – pain medication 4mm diameter, 44mm length holds 150µL drug and deliver at rate 0.4µL/day. Responsive delivery release – physiological signal Smart polymers – deliver drug – biological stimulus Antigen-antibody interaction Slide 9: Detection of S. aureus – increased thrombin – release antibiotic gentamicin Gentamicin bound-PVA hdrogel-peptide linker Thrombin-Biologically inactive–active by leucine aminopeptodase Self-relating insulin delivery devices – immobilizing glucose oxidase(GOx) in a pH-sensitive hydrogel Problems: Passive drug release, nonphysiological working pH, nonreproducible drug release, slow response time, biocompatability and limited lifetimes Slide 11: Microfabrication: Nonconventional MEMS polymeric materials – control surface hydrophilicity and minimize protein absorption Microreservoirs – store sensing reagents/active drug – solid or liquid form Eg. Microchip based device – mechanism - elecrochemical dissolution of metal cover film Soft hydrogel and polymer valves-mimic natural muscle Slide 13: Telemetry Wireless transmission of data Integrated with defibrillators, pumps or retinal prosthetics Monitor – intrauterine pressure changes,body temperature and heart rate of a fetus Pill sized wireless cameras and image sensors – endoscopic capsules Future perspectives and challenges : Future perspectives and challenges Properties of responsive drug delivery device Combination of sensing and delivery Small and easy to implant and remove, patient compliance Long-lived, Biocompatible and inexpensive Inert, mechanically strong, comfortable for patient Safe from accidental release, easy to fabricate and sterilize and allow high drug loading Continuous monitoring, telemetric data transfer and allow physician intervention if needed Slide 16: Control- circadian rhythm Covera-HS – hypertension/angina pectoris Norplant - Subcutaneous implantation –contraceptive device Incorporating telemetry – access – sensor and delivery at all times. Slide 17: Thank you You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.